ConvaTec Group PLC
Karim Bitar serves as the Chief Executive Officer of Convatec since September 2019, bringing extensive leadership experience from previous roles including Chief Executive Officer at Genus PLC (2011-2019) and President for Europe, Australia, and Canada at Eli Lilly and Company (1996-2011). Bitar's early career includes positions at McKinsey & Company as an Engagement Manager, Johnson & Johnson as a Brand Manager, and Dow as a Key Account Manager. Bitar has also contributed as a Non-Executive Director at Spectris plc (2017-2022), participating in audit, remuneration, and nomination committees. Academic credentials include an MBA with distinction from the University of Michigan and a BS in Biochemistry from the University of Wisconsin-Madison.
This person is not in any teams
This person is not in any offices
ConvaTec Group PLC
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets. Its products include FlexiSeal Signal, FlexiSeal Fecal Collector and Intermittent Catheters.